Translations:Cardiology/92/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 12:50, 4 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Cardiology)
* V-HeFT (1986) — use of vasodilators (hydralazine & isosorbide dinitrate) in heart failure
* ISIS-2 (1988) — use of aspirin in myocardial infarction
* CASE I (1991) — use of [[antiarrhythmic agent]]s after a heart attack increases mortality
* SOLVD (1991) — use of [[ACE inhibitor]]s in heart failure
* 4S (1994) — [[statin]]s reduce risk of heart disease
* CURE (1991) — use of [[dual antiplatelet therapy]] in [[NSTEMI]]
* MIRACLE (2002) — use of [[cardiac resynchronization therapy]] in heart failure
* SCD-HeFT (2005) — the use of [[implantable cardioverter-defibrillator]] in heart failure
* RELY (2009), ROCKET-AF (2011), ARISTOTLE (2011) — use of [[DOAC]]s in [[atrial fibrillation]] instead of warfarin
* PARADIGM-HF (2014) — use of angiotensin-neprilysin inhibitor in heart failure
* ISCHEMIA (2020) — medical therapy is as good as [[coronary stent]]s in stable heart disease
* EMPEROR-Preserved (2021) — SGLT2 receptors in heart failure
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Cardiology/92/en&oldid=124245"